Published in Nucleic Acids Res on December 01, 2006
The expanding universe of p53 targets. Nat Rev Cancer (2009) 3.49
Transcriptional regulation by p53. Cold Spring Harb Perspect Biol (2010) 3.16
Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res (2008) 2.67
The p53 family and programmed cell death. Oncogene (2008) 1.81
The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon. EMBO Rep (2009) 1.69
Life or death: p53-induced apoptosis requires DNA binding cooperativity. Cell Cycle (2010) 1.05
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes. BMC Med Genomics (2009) 0.88
Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. Nucleic Acids Res (2007) 0.86
Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements. Nucleic Acids Res (2010) 0.84
Pou4f1 and pou4f2 are dispensable for the long-term survival of adult retinal ganglion cells in mice. PLoS One (2014) 0.80
Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression. Cell Stress Chaperones (2008) 0.78
Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults. Cell Death Dis (2014) 0.75
Protein serine/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5. Sci Rep (2017) 0.75
Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study. PLoS Med (2016) 0.75
Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 15.06
p53: puzzle and paradigm. Genes Dev (1996) 13.16
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell (1994) 9.25
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 8.74
Regulation of the G2/M transition by p53. Oncogene (2001) 7.02
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97
Decision making by p53: life, death and cancer. Cell Death Differ (2003) 5.52
Mediation of c-Myc-induced apoptosis by p53. Science (1994) 4.45
ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell (2001) 4.38
Regulation of p53 downstream genes. Semin Cancer Biol (1998) 4.22
BAX is required for neuronal death after trophic factor deprivation and during development. Neuron (1996) 4.02
Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron (2000) 3.01
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature (1996) 2.81
Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J Neurosci (1998) 2.80
POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc Natl Acad Sci U S A (1996) 2.48
POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev Biol (1999) 2.11
Novel cell lines display properties of nociceptive sensory neurons. Proc Biol Sci (1990) 1.89
ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol (2004) 1.88
Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature (1996) 1.84
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns (1997) 1.75
Targeted deletion of the mouse POU domain gene Brn-3a causes selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. Proc Natl Acad Sci U S A (1996) 1.71
Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor. Cancer Biol Ther (2004) 1.57
Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. Dev Biol (1998) 1.44
A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res (1992) 1.41
The p53 gene family. Oncogene (1999) 1.35
Bax deficiency prevents the increased cell death of immature neurons in bcl-x-deficient mice. J Neurosci (1997) 1.35
p53-dependent pathways of apoptosis. Cell Death Differ (2001) 1.34
Myc: a weapon of mass destruction. Cell (2004) 1.29
The p53 pathway and its inactivation in neuroblastoma. Cancer Lett (2003) 1.29
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem (1999) 1.22
Functions of the BRCA1 and BRCA2 genes. Curr Opin Genet Dev (1998) 1.13
Cell cycle. Piecing together the p53 puzzle. Science (2000) 1.09
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol (1996) 1.06
The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene (1999) 1.04
Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate. J Biol Chem (2004) 1.02
The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis. J Biol Chem (2000) 1.01
Activation of the alpha-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J Biol Chem (1995) 0.97
BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat (1999) 0.96
Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor. J Biol Chem (1995) 0.93
Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. Oncogene (1993) 0.93
The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Mol Cell Biol (1997) 0.92
Chromosomal localization and sequences of the murine Brn-3 family of developmental control genes. Cytogenet Cell Genet (1994) 0.91
Coordinate induction of the three neurofilament genes by the Brn-3a transcription factor. J Biol Chem (1997) 0.91
Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res (2005) 0.90
POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol Cell Biol (1998) 0.90
The role of TP53 in breast cancer development. Cancer Surv (1993) 0.90
Targeting Brn-3b in breast cancer therapy. Expert Opin Ther Targets (2006) 0.89
The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J Biol Chem (2004) 0.87
The Brn-3a transcription factor. Int J Biochem Cell Biol (1998) 0.87
Coexpression of Brn-3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis. J Neurosci Res (2004) 0.85
The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells. Oncogene (2001) 0.84
Inhibition of neuronal process outgrowth and neuronal specific gene activation by the Brn-3b transcription factor. J Biol Chem (1997) 0.83
Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter. Nucleic Acids Res (2002) 0.82
The Brn-3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells. Int J Cancer (2006) 0.82
The levels of the antagonistic POU family transcription factors Brn-3a and Brn-3b in neuronal cells are regulated in opposite directions by serum growth factors. Neurosci Lett (1995) 0.81
Differential regulation of genes encoding synaptic proteins by members of the Brn-3 subfamily of POU transcription factors. Brain Res Mol Brain Res (1996) 0.80
Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene (2006) 0.80
Distinct susceptibility of developing neurons to death following Bax overexpression in the chicken embryo. Cell Death Differ (2006) 0.78
Sensory neurons from mice lacking the Brn-3b POU family transcription factor are resistant to death-inducing stimuli both in vitro and in vivo. Brain Res Mol Brain Res (2003) 0.77
The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. Neurosci Lett (2002) 0.77
Cell cycle arrest and morphological differentiation can occur in the absence of apoptosis in a neuronal cell line. Neurosci Lett (1994) 0.76
The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells. Int J Cancer (1996) 0.76
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 20.16
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17
Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation (2010) 2.57
Costs of ABO incompatible living donor transplantation are justified. Transplantation (2006) 2.07
Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res (2005) 1.99
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem (2006) 1.91
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol (2006) 1.83
STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem (2003) 1.79
Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology (2003) 1.76
Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress. Am J Physiol Heart Circ Physiol (2007) 1.70
A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol (2006) 1.61
Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (2010) 1.60
Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor. Cancer Biol Ther (2004) 1.57
Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury. Int J Cardiol (2011) 1.52
Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Transplantation (2012) 1.50
The quality of reporting of randomized controlled trials in solid organ transplantation. Transpl Int (2008) 1.46
The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem (2002) 1.45
Compliance to the CONSORT statement of randomized controlled trials in solid organ transplantation: a 3-year overview. Transpl Int (2013) 1.44
STAT-1: a novel regulator of apoptosis. Int J Exp Pathol (2003) 1.43
Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci U S A (2002) 1.41
Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy. World J Surg (2014) 1.38
Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J Alzheimers Dis (2009) 1.34
PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73. Mol Cell Biol (2004) 1.33
Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med (2006) 1.32
Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J (2004) 1.31
The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Biol Chem (2003) 1.24
Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Transplantation (2009) 1.22
Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res (2002) 1.18
Retracted STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J Cell Sci (2005) 1.17
The clinical benefits of cyclosporine C2-level monitoring: a systematic review. Transplantation (2007) 1.17
Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review. Transplantation (2008) 1.16
BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol (2005) 1.14
Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States. J Acquir Immune Defic Syndr (2015) 1.12
Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum (2007) 1.12
Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol Dis (2007) 1.11
Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem Biophys Res Commun (2003) 1.10
Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol (2002) 1.09
HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells. J Neurochem (2004) 1.09
Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res (2002) 1.09
Tuberculosis in renal transplant recipients: the evidence for prophylaxis. Transplantation (2010) 1.08
Molecular basis of Parkinson's disease. Neuroreport (2009) 1.06
Neuroprotective effects of HSP70 overexpression after cerebral ischaemia--an MRI study. Exp Neurol (2005) 1.05
Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum Mol Genet (2007) 1.03
STAT3 deletion sensitizes cells to oxidative stress. Biochem Biophys Res Commun (2009) 1.02
Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate. J Biol Chem (2004) 1.02
IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovasc Res (2005) 1.02
Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Brain Res Mol Brain Res (2004) 1.02
The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J (2002) 1.01
ERK and the F-box protein betaTRCP target STAT1 for degradation. J Biol Chem (2008) 1.00
Stressful preconditioning and HSP70 overexpression attenuate proteotoxicity of cellular ATP depletion. Am J Physiol Cell Physiol (2002) 1.00
STAT3 modulates the DNA damage response pathway. Int J Exp Pathol (2010) 1.00
Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol (2002) 1.00
The outcome of pediatric cadaveric renal transplantation in the UK and Eire. Pediatr Transplant (2002) 0.99
The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1. Oncogene (2004) 0.99
STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest. Cell Cycle (2010) 0.99
Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials. Transpl Int (2011) 0.98
Neuroprotective effects of virally delivered HSPs in experimental stroke. J Cereb Blood Flow Metab (2006) 0.98
An analysis of the Research Fellowship Scheme of the Royal College of Surgeons of England. J Am Coll Surg (2005) 0.97
Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo. J Cereb Blood Flow Metab (2008) 0.96
Introduction: Paving the way for biomedical HIV prevention interventions in youth. J Acquir Immune Defic Syndr (2010) 0.95
Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol (2002) 0.95
Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injury. FASEB J (2006) 0.94
BAG-1 proteins protect cardiac myocytes from simulated ischemia/reperfusion-induced apoptosis via an alternate mechanism of cell survival independent of the proteasome. J Biol Chem (2004) 0.94
Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res (2002) 0.93
Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Hum Mol Genet (2003) 0.93
Quantitative assessment of fat infiltration in the rotator cuff muscles using water-fat MRI. J Magn Reson Imaging (2013) 0.92
Femoroacetabular Impingement: Prevalent and Often Asymptomatic in Older Men: The Osteoporotic Fractures in Men Study. Clin Orthop Relat Res (2015) 0.92
How do antiphospholipid antibodies bind beta2-glycoprotein I? Arthritis Rheum (2003) 0.92
Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia. J Cereb Blood Flow Metab (2009) 0.92
Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition. Neurobiol Dis (2005) 0.92
The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transpl Int (2004) 0.91
New targets of urocortin-mediated cardioprotection. J Mol Endocrinol (2010) 0.91
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. Chembiochem (2005) 0.91
Transcriptional modulation of heat-shock protein gene expression. Biochem Res Int (2010) 0.91
CREB-binding protein activation by presenilin 1 but not by its M146L mutant. Neuroreport (2006) 0.91
Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res (2005) 0.90
Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation. Transplantation (2004) 0.90
The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int (2005) 0.90
Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin. Mol Immunol (2003) 0.90
A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli. BMC Biotechnol (2006) 0.90
Heart disease and stroke in North Carolina. N C Med J (2013) 0.90
Heat shock protein 70 or heat shock protein 27 overexpressed in human endothelial cells during posthypoxic reoxygenation can protect from delayed apoptosis. Cell Stress Chaperones (2003) 0.90
The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage. Biochem Biophys Res Commun (2004) 0.89
Targeting Brn-3b in breast cancer therapy. Expert Opin Ther Targets (2006) 0.89
Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome. Arthritis Rheum (2007) 0.88
STAT1 regulates p73-mediated Bax gene expression. FEBS Lett (2007) 0.88
The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J Biol Chem (2004) 0.87
Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss. Brain Res Mol Brain Res (2003) 0.87
Hsf1-mediated stress response can transiently enhance cellular radioresistance. Radiat Res (2006) 0.86
p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1. Cell Cycle (2008) 0.86
Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways. J Immunol (2010) 0.86
Anatomic correlates of reduced hip extension during walking in individuals with mild-moderate radiographic hip osteoarthritis. J Orthop Res (2015) 0.86
p300 activation by Presenilin 1 but not by its M146L mutant. Neurosci Lett (2007) 0.86
Induction of parkin expression in the presence of oxidative stress. Eur J Neurosci (2006) 0.86